How long does production take?

The average lead time is 1-3 months for both peak and off-peak seasons.

Do you offer OEM and ODM services?

Yes, we offer OEM and ODM services with options for full, minor, sample-based, or design-based customization.

What is your production capacity?

Our production capacity is 1 billion small-volume injections.

Artemether 80mg + Lumefantrine 480mg Tablets USP/Bp Malaria Tablets Supplier

Name: Artemether 80mg + Lumefantrine 480mg Tablets USP/Bp Malaria Tablets Supplier
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 1968442461

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.10

300,000 Pieces

Product profile

Customization

Available

Application

Neurology

Usage Mode

Injectable

Suitable for

Elderly, Adult

State

Solid

Shape

Tablet

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Shelf Life

3 Years

HS

3004909099

Pharmacopoeia

Bp/Cp/USP, etc.

Registration Dossiers

Available

GMP

Support

Capacity of Production

1 Billion Small-Volume Injections

Transport Package

Boxes and Carton

Specification

80+480

Trademark

OEM

Origin

China

Key features

GMP Certified Factory: High performance tablets produced in a GMP certified facility ensuring quality and safety.

Custom Production Support: Support for custom tablet shapes, colors, sizes, and packaging boxes based on client needs.

Diverse Dosage Forms: Offers dispersible, oral disintegrating, sublingual, chewable tablets, capsules, granules, and more.

Registration Documents Support: Provides GMP certificate, COPP, FSC, and CTD format dossiers for regulatory compliance.

OEM and ODM Services: Full customization options available from samples, designs, or minor adjustments.

High Production Capacity: Capable of producing up to 1 billion small-volume injections annually.

Strict Quality Control: 100% inspection of finished products including visual and function checks.

Experienced Manufacturer: Established in 2001 with 20 years of export experience and professional R&D team.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.